Anti-Dnase B Reagent System

FDA 510(k) K790997 · Calbiochem-Behring Corp.

Substantially Equivalent

510(k) numberK790997

Submission

Device name
Anti-Dnase B Reagent System
Applicant
Calbiochem-Behring Corp.
Mchenry, IL, US
Received
May 29, 1979
Decision date
July 24, 1979
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
GTR – Antideoxyribonuclease, Streptococcus Spp.
Device class
Class I (low risk)
Regulation
21 CFR 866.3720
Specialty
Microbiology

More from Calbiochem-Behring Corp.

510(k)DeviceDecision
K831811Revolution Radial Immunodiffusion PlateJZQ · Traditional 07/28/1983SE
K831036Ena Test Kit SM & RNP Auto AntibodyLLL · Traditional 04/27/1983SE
K830214Aft System IIIDHN · Traditional 03/09/1983SE
K820812Creatine Kinase-Mb KitJHY · Traditional 04/12/1982SE
K813493Enzygnost TM Rubella IgmLFX · Traditional 03/04/1982SE
K820088Aft System Proficiency Testing ProgramDBL · Traditional 01/26/1982SE
K812458PadacJTO · Traditional 09/23/1981SE
K810718C-Peptice ReagentsJKD · Traditional 03/31/1981SE
K810669Pantrak E.K.CIW · Traditional 03/31/1981SE
K810404Rheumatoid Factors Reference SerumDHR · Traditional 03/11/1981SE

Questions and answers

When was Anti-Dnase B Reagent System cleared by the FDA?

Anti-Dnase B Reagent System (K790997) received a 510(k) decision of Substantially Equivalent on July 24, 1979, 56 days after the submission was received.

What is the product code of K790997?

The FDA product code is GTR – Antideoxyribonuclease, Streptococcus Spp., a Class I (low risk) device regulated under 21 CFR 866.3720.